Lecture 05 - Inflammatory Mediators Flashcards
Inflammatory Mediators
- Cell derived
2. Plasma derived protein
Cell Derived Inflammatory Mediators: 1. Vasoactive Amines
- Histamine: transient effect –> 15’
- vasodilation
- increased vessels permeability
- endothelium activation
Stimulator: - Stress
- IgE on mast cells
- Anaphylatoxins: C5a, C3a
- Cytokines: IL-1,8
- Neuropeptides
- Histamine Releasing Peptide
- Serotonin: by platelet, neuroendocrine cells of GI tract, mast cells of ????
Roles:
- neurotransmitter in GI tract
- vasoconstriction
Stimulator:
Platelet aggregation
Cell Derived Inflammatory Mediators: 2. Eicosanoids
Metabolites of arachidonic acid (linoleic acid) –> phospholipase:
- LTs, LXs: arachidonic acid –> 5-lipoxygenase –> 5-HPETE –> 1. LTs 2. 12-lipoxygenase –> LXs
- LTC4,D4,E4 –> bronchospasm, increased vascular permeability
- LXA4,B4 –> neutrophil adhesion and chemotaxis inhibition - PGs: arachidonic acid –> cyclooxygenase –> PGG2 –>PGH2 –> …
- PGI2 (prostacyclin): vasodilation, inhibition of platelet aggregation
- PGB4: PMN activator, chemotaxis, ROS generation, release of lysosomal enzymes
- TXA2 –> vasoconstriction, promotion of platelet aggregation
- PGD2,E2,F2: vasodilation, edema
Phospholipase Inhibitors
- -> no arachidonic acid –> no LTs or PGs
- Corticosteroids
- Dexametazone
- prednisone
- prednisolone
COX Inhibitors
–> no PGs
- maximum pain endurance increased
- GI tract toxicity –> COX-2(inflammation specific) inhibitor
NSAIDs
- ibuprofen
- ketoprofen
- naproxen
- mefenamic acid(COX-2)
- aspirin(COX-2)
- piroxicam
- indomethacin
- phenylbutazone
Lipoxygenase Inhibitor
- zileuton
- montelukast –> LT receptor antagonist
Cell Derived Inflammatory Mediators: 3. PAF
Based on phospholipids Roles: 1. Platelet aggregation and activation 2. Increased vascular permeability 3. Chemotaxis an adhesion 4. Leukocyte aggregation 5. Stimulation of other mediators Sources: Mast cells/basophils Neutrophil Monocytes/macrophage Endothelium Platelets
Cell Derived Inflammatory Mediators: 4. Cytokines
Produces more leukocytes TNF, IL-1 by macrophages when activated --> bacteria, immune complex, toxin, trauma, other cytokines Level of activity: 1. Acute Phase Reaction 2. Effect on Endothelial cells 3. Effect on Fibroblasts 4. Effect on Leukocytes
- Acute Phase Reaction
fever, sleepiness, loss of appetite, APP, shock, increased neutrophils
- Effect on Endothelial cells
increase leukocyte adhesion, increased PGI2, increased thrombi activity, decreased anti-thrombi activity, increased production of IL-1,6 and PDGF
- Effect on Fibroblasts
increased fibroblast, secretion of collagen and collagenase + protease, PGE synthesis induction
- Effect on Leukocytes
increased secretion and production of IL-1,6
Systemic Effects of a Local Inflammation
- IL-1,6, TNF –> brain stem –> fever
- IL-1,6 –> liver –> APP
- IL-1,6, TNF –> increased leukocyte production
Pathological Effect of Local Inflammation
- TNF –> heart –> low output –> septic shock
- TNF –> endothelium –> thrombosis
- TNF, IL-1 –> skeletal muscle –> insulin resistence
Cell Derived Inflammatory Mediators: 5. Chemokines
- CXC –> neutrophils
- CC –> monocytes
- C –> lymphocytes
- chmetaxis and leukocyte activation